Martinus T Maria De Jong

Title: Martinus T Maria De Jong: Innovator in Radiolabeled Peptide Stabilization

Introduction

Martinus T Maria De Jong is a notable inventor based in Hoogkarspel, Netherlands. He has made significant contributions to the field of biochemistry, particularly in the stabilization of radiolabeled peptides. His innovative work has implications for various applications in medical research and diagnostics.

Latest Patents

Martinus holds a patent for "Stabilizers to prevent autoradiolysis of radiolabeled peptides." This patent details the use of gentisic acid and its derivatives, which substantially inhibit peptide autoradiolysis. Additionally, it highlights that gentisic acid or its derivatives may be used in combination with other stabilizers, such as inositol and ascorbic acid, to further inhibit autoradiolysis of radiolabeled peptides. He has 1 patent to his name.

Career Highlights

Martinus is currently employed at Mallinckrodt Medical, Inc., where he continues to advance his research in the field. His work is crucial in developing methods that enhance the stability of radiolabeled compounds, which are essential for accurate medical imaging and therapeutic applications.

Collaborations

Throughout his career, Martinus has collaborated with esteemed colleagues, including Edward A Deutsch and Wilhelmus T Goedemans. These partnerships have fostered a collaborative environment that promotes innovation and the sharing of ideas in the scientific community.

Conclusion

Martinus T Maria De Jong is a distinguished inventor whose work in stabilizing radiolabeled peptides has made a significant impact in the field of biochemistry. His contributions continue to influence medical research and diagnostics, showcasing the importance of innovation in science.